Dr. Liana Billings
Claim this profileNorthShore University Health System
Studies Type 2 Diabetes
Studies Obesity
5 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Liana Billings is currently running
LY3841136 + Tirzepatide
for Obesity with Type 2 Diabetes
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes. Participation in the study will last about 64 weeks.
Recruiting0 awards Phase 2
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
More about Liana Billings
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Liana Billings has experience with
- Tirzepatide
- LY3526318
- Dulaglutide
- LY3841136
- LY3549492
- IVA337
Breakdown of trials Liana Billings has run
Type 2 Diabetes
Obesity
Childhood Obesity
Reflex Sympathetic Dystrophy (RSD)
Autonomic Neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Liana Billings specialize in?
Is Liana Billings currently recruiting for clinical trials?
Are there any treatments that Liana Billings has studied deeply?
What is the best way to schedule an appointment with Liana Billings?
What is the office address of Liana Billings?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.